The results showed that the levels of CCL17, CXCL14, and CXCR3 in cancer were 1.558 ± 0.104 ng/ml, 2.169 ± 0.214 ng/ml, and 2.843 ± 0.423 ng/ml, respectively, significantly lower than the corresponding adjacent tissues 1.795 ± 0.207 ng/ml, 2.625 ± 0.093 ng/ml, and 6.868 ± 0.455 ng/ml (p < 0.05 or 0.01, Figure 7). Here, CXCL14 is linked to cancer.